140 related articles for article (PubMed ID: 6237082)
1. The effect of timing on chemosensitization by clinical levels of SR-2508.
Hirst DG; Horsman MR; Brown JM; Hazlehurst JL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1641-5. PubMed ID: 6237082
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
Hirst DG; Hazlehurst JL; Brown JM
Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
5. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Wallen CA; Moore SK; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
[TBL] [Abstract][Full Text] [Related]
6. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
7. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
8. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.
Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089
[TBL] [Abstract][Full Text] [Related]
9. Sensitization by SR-2508 plus Ro 03-8799.
Stone HB; Luu YH; Lam KN
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
McNally NJ; Hinchliffe M; de Ronde J
Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Martin WM; McNally NJ; De Ronde J
Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
13. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
Brown JM; Yu NY
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
[TBL] [Abstract][Full Text] [Related]
16. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
20. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
